• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
p53
 

p53

on

  • 625 views

 

Statistics

Views

Total Views
625
Views on SlideShare
625
Embed Views
0

Actions

Likes
0
Downloads
19
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    p53 p53 Presentation Transcript

    • p53THE TUMORSUPPRESSOR Presented by Spoorthi shridhar MSc. biochemistry
    • INTRODUCTION• Tumor Suppressor• 53 kDa protein• Encoded by TP53 gene• Regulates cell cycle
    • HISTORY• 1979 - David Lane and Lionel Crawford• 1983 - The term “p53” was coined• p53 acknowledged as an oncogene• 1984 - David Wolf and Rotter• 1989 - p53 tagged as a tumor suppressor
    • STRUCTURE
    • AMINO TERMINAL DOMAIN transactivation transcription factors – MDM2 PROLINE-RICH REGION stability CENTRAL CORE DNA binding domain C-TERMINAL DOMAIN negative regulation
    • STABILITY OF P53
    • ACTIVATION PHYSICAL AGENTS: UV, gamma, X-raysCHEMICAL AGENTS: carcinogens chemotherapeutic agents alkylating agentsOTHER CAUSES hypoxia heat shock
    • FUNCTIONS activation in response to stress stimuli prevents inappropriate cell proliferation: cell cycle arrest apoptosis
    • CELL CYCLE ARREST IN G1 PHASE Molecular Biology Of The Cell Bruce Alberts
    • CELL CYCLE ARREST IN G2 PHASE p53 Gadd 45 CDK1 Cyclin B/CDK1 Prevents phosphorylation
    • APOPTOSIS
    • MUTATIONS
    • LUNG CANCER:• 33% in adenocarcinomas to 70% in small cell lung cancers• GC to TA transversions• Exogenous carcinogens such as benzopyrene• Codons 157, 248 and 273UV AND SKIN CANCERS:• CC to TT transitions• Codons 245 and 247/248COLORECTAL CANCER:• 34% proximal colon tumors• 45% distal colon and rectal tumors
    • Molecular Cell Biology Lodish Et al.
    • THERAPEUTIC APPLICATIONS• Inhibiting interaction of MDM2 with p53• Small molecule inhibitors: nutlins• Antisense oligodeoxy nucleotides• Inhibiting E6 protein of Human Papilloma Virus• Leptomycin B and Actinomycin D
    • • Induction of apoptotic pathways• Introduction of wt p53 gene into tumors GENE THERAPY:• 2004 - treatment of head and neck cancer in China• McCormick and co-workers, USA - infection of the tumor with recombinant adenovirus.